Neurostimulation for Spinal Cord Injury
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore how the brain and nerves connect to the diaphragm, which is crucial for breathing, after a spinal cord injury in the neck area. Researchers seek to determine if combining neurostimulation (a type of electrical stimulation) with breathing exercises can enhance breathing and recovery in individuals with breathing issues due to this type of injury. Participants will undergo multiple sessions of stimulation on the head and neck, followed by respiratory training. This trial is best suited for individuals who have had a cervical spinal cord injury for at least six months and are experiencing breathing problems, such as those needing mechanical ventilation or having reduced lung function. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could improve breathing treatments for spinal cord injury patients.
Will I have to stop taking my current medications?
The trial requires that you stop taking certain medications, specifically Bupropion, Dolutegravir, Lacosamide, Trilaciclib, or drugs that prolong the PR Interval. If you are on any of these, you would need to stop them to participate.
What prior data suggests that this neurostimulation and respiratory training is safe for spinal cord injury patients?
Research has shown that neurostimulation is generally safe for people with spinal cord injuries. One study found that non-invasive electrical stimulation of the spinal cord was well-received and improved hand and arm movement in people with neck-level spinal cord injuries, with no serious side effects reported. However, another study raised concerns, noting cases of autonomic dysreflexia—a condition that can cause a sudden increase in blood pressure—associated with electrical stimulation techniques. Prospective participants should discuss possible risks with the research team before joining a trial.12345
Why are researchers excited about this trial?
Researchers are excited about neurostimulation for spinal cord injury because it offers a novel way to improve respiratory function, which is a critical area often impacted by such injuries. Unlike traditional treatments that might focus on physical rehabilitation or mechanical ventilation, neurostimulation uses electrical impulses to directly target and enhance the neural pathways that control breathing. This method has the potential to restore respiratory function more effectively by reactivating the body's own neural control systems. It's a promising approach that could significantly enhance quality of life for individuals with spinal cord injuries by improving an essential and often compromised bodily function.
What evidence suggests that neurostimulation and respiratory training could be effective for spinal cord injury?
Research has shown that certain types of electrical stimulation can help people with cervical spinal cord injuries breathe better. This trial studies neurostimulation's effects on respiratory function. One method, transcutaneous spinal cord stimulation, strengthens and improves breathing muscles. Other studies suggest that techniques like epidural and functional electrical stimulation may aid recovery in spinal cord injuries. Specifically, using electrical stimulation on the abdomen has improved breathing. These findings suggest that neurostimulation could be a promising way to enhance breathing in individuals with spinal cord injuries.678910
Who Is on the Research Team?
Monica Perez, PhD
Principal Investigator
Shirley Ryan AbilityLab
Are You a Good Fit for This Trial?
This trial is for adults aged 18-85 with a cervical spinal cord injury at C1-C5 level, at least 6 months post-injury. They must have respiratory deficits and either use mechanical ventilation or have vital capacity less than 80% predicted. A family member or caregiver must be able to operate the ventilator during visits. Exclusions include dependence on diaphragmatic pacer, certain medications, brain injuries, seizures, pregnancy, metal in skull, other major illnesses or conditions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 40 treatment sessions including multiple stimulation sessions over the scalp and neck, followed by about 60 minutes of respiratory training
Assessment
Assessment sessions are completed at baseline, after 20 sessions, and after 40 sessions of study treatment
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Neurostimulation
- Respiratory training
Neurostimulation is already approved in United States, European Union for the following indications:
- Respiratory dysfunction in spinal cord injury patients
- Respiratory failure in spinal cord injury patients
- Neuropathic pain relief
Find a Clinic Near You
Who Is Running the Clinical Trial?
Shirley Ryan AbilityLab
Lead Sponsor